The intestinal immune system is exposed to a mixture of foreign antigens from diet, commensal flora and potential pathogens. Understanding how pathogen-specific immunity is elicited while avoiding inappropriate responses to the background of innocuous antigens is essential for understanding and treating intestinal infections and inflammatory diseases. The ingestion of protein antigen can induce oral tolerance, which is mediated in part by a subset of intestinal dendritic cells (DCs) that promote the development of regulatory T cells 1 . The lamina propria (LP) underlies the expansive single-cell absorptive villous epithelium and contains a large population of DCs (CD11c 1 CD11b 1 MHCII 1 cells) comprised of two predominant subsets: CD103 1 CX 3 CR1 2 DCs, which promote IgA production, imprint gut homing on lymphocytes and induce the development of regulatory T cells [2] [3] [4] [5] [6] [7] [8] [9] , and CD103 2 CX 3 CR1 1 DCs (with features of macrophages), which promote tumour necrosis factor-a (TNF-a) production, colitis, and the development of T H 17 T cells [5] [6] [7] 10 . However, the mechanisms by which different intestinal LP-DC subsets capture luminal antigens in vivo remains largely unexplored. Using a minimally disruptive in vivo imaging approach we show that in the steady state, small intestine goblet cells (GCs) function as passages delivering low molecular weight soluble antigens from the intestinal lumen to underlying CD103 1 LP-DCs. The preferential delivery of antigens to DCs with tolerogenic properties implies a key role for this GC function in intestinal immune homeostasis.
We examined the in vivo antigen acquisition behaviour of intestinal LP-DCs in fluorescent DC-reporter mice using two-photon microscopy ( Supplementary Fig. 1a ). The intestine is imaged within the peritoneal cavity and images can be acquired from either the intact intestinal serosa or from the luminal surface through a small longitudinal incision in the intestine (Fig. 1a, b and Supplementary Movie 1, upper panels). The preparation is sufficiently stable to permit three-dimensional imaging of DC behaviour deep within intestinal tissues ( Fig. 1c and Supplementary Movie 1, lower left panel) and preserves blood flow and epithelial barrier integrity for more than 4 h of continuous imaging.
We assessed antigen distribution by two-photon microscopy following the intraluminal injection of 10 kDa rhodamine dextran as a model antigen. Dextran coated the surface of the epithelium and filled the space between villi and crypts ( Fig. 1a, b ). In addition, we observed cylindrical dextran columns approximately 5 mm in diameter and about 20 mm long projecting through the villus epithelium and into the LP, when imaging from either serosal or luminal orientations ( Fig. 1a -c, Supplementary Fig. 1b and Supplementary Movie 1, upper panels and lower right panel). Transepithelial dextran columns were common throughout the small intestine from duodenum to ileum, but did not cause a general disruption of the epithelial barrier as shown by the exclusion of dextran from the LP (Fig. 1a-c ). We did not detect transepithelial dextran columns in the stomach, caecum, or colon, with the exception of the epithelium overlying the caecal patches ( Supplementary Fig. 1c -e and Supplementary Movie 2). Confocal microscopy revealed that dextran columns were a subset of epithelial cells containing intracellular dextran, which had a continuous border of e-cadherin on their basolateral surface and were often in contact with yellow fluorescent protein (YFP 1 ) cells in the LP of CD11c-YFP reporter mice 30 (Fig. 1d , e and Supplementary Movie 4, right panel).
Periodic acid-Schiff staining of mucin in sections of the small intestine ( Fig. 2a ) produced a goblet cell (GC) staining pattern similar in frequency, distribution and dimensions to the dextran columns identified by two-photon microscopy (Fig. 2b, c ). Furthermore, in contrast to the acellular and impermeable discontinuities seen in the small intestine epithelium 11 , dextran columns were associated with a nucleus ( Fig. 2d , Supplementary Fig. 2a and Supplementary Movie 3). To determine if the dextran-filled cells were in fact GCs, sections of intestine from mice given lysine-fixable dextran were stained with antibodies to mucin 2 (MUC2) and cytokeratin 18, which are both highly expressed by GCs 12 . Dextran columns showed near perfect colocalization with MUC2 1 and cytokeratin 18 1 epithelial cells displaying GC morphology ( Fig. 2e, f ). Therefore, we term this phenomenon 'goblet-cell-associated antigen passages' (GAPs). To address the possibility that GAPs are apoptotic GCs, we co-stained for various markers of apoptosis, including cleaved cytokeratin 18, cleaved caspase 3 and TdT-mediated dUTP nick end labelling (TUNEL; Supplementary Fig. 3a -i). In all cases, we found no association between apoptotic GCs and GAPs. Moreover, GAPs are distinct from villous M cells, because they did not colocalize with the M-cell marker glycoprotein 2 (GP2) ( Fig. 2g) 13 . The frequency and distribution of GAPs assessed by two-photon microscopy was similar in all strains of specific-pathogen-free (SPF) mice examined (Supplementary Fig. 2b-d) , with a non-significant trend toward more GAPs detected in the terminal ileum ( Supplementary Fig. 2h ). GAPs were also evident in human jejunum resection specimens ( Fig. 2h , i), suggesting that GAPs are a general phenomenon of the healthy small intestine. We examined the frequency of GAPs in C3H/HejBir IL-10 2/2 mice 14 , which develop spontaneous intestinal inflammation with GC loss, and in germ-free mice that lack normal gut flora. The number of GAPs and GCs correlated strongly; GAPs and GCs were significantly more numerous in germ-free mice ( Supplementary Fig. 2e , g) and significantly fewer in IL-10 2/2 mice ( Supplementary Fig. 2f , g).
Previous studies have shown that LP-DCs can extend transepithelial dendrites (TEDs) between intestinal epithelial cells to sample luminal contents and microbiota [15] [16] [17] [18] . However, these studies used ex vivo and exteriorized tissue preparations that involved removing the luminal contents and mucous before imaging. Using our in vivo imaging preparation and confocal microscopy, we found that although LP-DCs probed the epithelium actively with their dendrites ( Fig. 1c and Supplementary Movie 1, lower left panel, and Supplementary Movie 4), they did not extend TEDs into the intestinal lumen to capture fluorescent antigen in healthy mice (based on over 50 independent intravital imaging experiments examining all regions of the small intestine from the tip of the villi to the base of the crypts). To confirm that our imaging approach can readily detect TEDs, we imaged CD11c-YFP reporter mice challenged with Salmonella typhimurium, which has been shown to upregulate TED formation 15 . Although rare LP-DC TEDs were observed in approximately 2% of villi, TEDs did not mediate the uptake of luminal dextran or beads on the basis of fluorescence colocalization ( Supplementary Fig. 4a and Supplementary Movie 5, upper left panel).
Next, we examined whether paracellular leak 19 could serve as a major source of luminal antigen for small intestine LP-DCs. The intraluminal injection of 5 mg of 10 kDa dextran produced a faint 'feather'-like staining pattern between villous epithelial cells, consistent with paracellular leak ( Supplementary Fig. 4b and Supplementary Movie 5, upper right panel). Time-lapse two-photon imaging showed that dextran collected at the base of the epithelium, but was flushed out of the villi efficiently during contraction and did not remain colocalized with LP-DCs even in areas of extensive paracellular leak ( Supplementary Fig. 4b and Supplementary Movie 4, left panel, and Supplementary Movie 5, upper right panel). In addition, we did not detect paracellular leak around GAPs in fixed sections by confocal microscopy, despite the more permissive tight junctions of GCs 20 . However, we cannot exclude the possibility that LP-DCs capture low levels of antigen via paracellular leak, because this process might be below the level of detection of our imaging approach.
In contrast to TEDs and paracellular leak, two-photon time-lapse imaging provided direct evidence that GAPs are a source of luminal antigen for LP-DCs. In addition to dextran ( Fig. 3a ), GAPs were capable of transporting protein antigens ( Fig. 3b ). Although most GAPs remained visible for the duration of our imaging experiments, they were a dynamic phenomenon (Supplementary Movie 5, lower panels). Moreover, the manner in which LP-DCs interacted with GAPs varied. In some cases, DCs made stable contacts and slowly collected antigen over several minutes ( Fig. 3a and Supplementary Movie 5, lower left panel) whereas in others, DCs actively probed GAPs and captured clumps of antigen ( Fig. 3b and Supplementary Movie 5, lower right panel). We assessed the molecular weight exclusion limit of GAPs and found that beads ranging from 0.02 to 1.0 mm in size did not enter GAPs ( Supplementary Fig. 4c ). In contrast, GAPs filled rapidly with 10 kDa dextran ( Supplementary Fig. 4d ) and dextran colocalized with CD11c-YFP 1 LP-DCs 2 h after intraluminal injection ( Fig. 3a and Supplementary Movie 5, lower left panel). GAPs also filled with larger dextrans ( Supplementary Fig. 4d ); however, capture by LP-DCs was markedly reduced with 70 kDa dextran and undetectable with 2,000 kDa dextran during our 4-h imaging window.
The small intestine LP contains two prominent DC populations: CX 3 CR1 2 CD103 1 DCs with tolerogenic potential and CX 3 CR1 1 CD103 2 DCs that have features of macrophages and have been implicated in intestinal inflammation [5] [6] [7] [8] [9] [10] . We visualized LP-DC subsets in vivo using dual-reporter mice created by crossing CD11c-YFP mice with CX 3 CR1-GFP knock-in mice (ref. 28) in which CD103 2 and CD103 1 LP-DCs can be distinguished by the presence or absence of CX 3 CR1-GFP expression, respectively ( Fig. 3c and Supplementary Fig.  5 ). We frequently observed CD11c-YFP 1 CX 3 CR1-GFP 2 LP-DCs sampling GAPs by two-photon microscopy, but this behaviour was rare in CD11c-YFP 1 CX 3 CR1-GFP 1 LP-DCs ( Fig. 3c and Supplementary Fig. 6c ); out of 50 total LP-DCs containing dextran, 49 were CD11c-YFP 1 CX 3 CR1-GFP 2 . Furthermore, when we directly observed antigen transfer from GAPs to DCs (20 out of 500 GAPs examined), GAPs delivered antigen exclusively to CD11c-YFP 1 CX 3 CR1-GFP 2 LP-DCs (Fig. 3d ). Immunofluorescence microscopy confirmed that the cells interacting with GCs were CD103 1 CD11c 1 LP-DCs and not B220 1 plasmacytoid DCs (pDCs) ( Supplementary  Fig. 6a ). Moreover, flow cytometry showed that luminal antigen was captured preferentially by CD103 1 DCs at a proportion of roughly 10:1 over CD103 2 DCs (Fig. 3e ) and rarely colocalized with pDCs (Supplementary Fig. 6b ), consistent with the sampling bias observed by twophoton imaging. Control experiments demonstrated that antigen uptake during cell isolation was negligible ( Supplementary Fig. 7) , thus the flow cytometry results measure the in vivo antigen acquisition capacity of different LP-DC subsets. Interestingly, CD103 1 LP-DCs, but not CD103 2 LP-DCs, often stained positive for cytokeratin 18 (Fig. 3f and g) , which is highly expressed by villous GCs (Fig. 3h ). 
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Because cytokeratin 18 expression is undetectable in LP-DCs by quantitative real-time PCR (Fig. 3h ), this suggests that CD103 1 LP-DCs interact selectively with GAPs and can capture GC-derived proteins.
In two-photon imaging experiments, LP-DCs captured fluorescent luminal ovalbumin (Ova) readily from GAPs (Fig. 4a and Supplementary Movie 6), similarly to fluorescent dextran and BSA. To determine if LP-DCs could process and present luminal antigen, we administered Ova in vivo, then sorted LP-DCs and co-cultured them with OTI T cells 21 . T-cell proliferation was assessed on day 3 by both CFDA (dye) dilution (Fig. 4b, c ) and by counting T cells after culture (Fig. 4d ). Total LP-DC populations (CD45 1 , CD11c 1 , MHCII 1 ) were capable of inducing modest OTI T-cell proliferation that was significantly greater than controls (Fig. 4b, d ). CD103 1 LP-DCs stimulated significant OTI T-cell proliferation, whereas CD103 2 LP-DCs from the same mice did not (Fig. 4d ). The failure of CD103 2 LP-DCs to stimulate T cells was not due a lack of intrinsic antigen presentation capacity, because they were capable of inducing comparable levels of OTI T-cell proliferation to CD103 1 LP-DCs (81.4% to 88.2%, respectively) when Ova was added to the cell culture ( Fig. 4c ). These findings suggest that CD103 1 LP-DCs have cross-presentation capacity, similar to their mesenteric lymph node counterparts 2 .
In some two-photon time-lapse recordings we observed GAPs forming or disappearing (Supplementary Movies 3 and 5, lower panels), suggesting that GAP formation could be related to changes in GC function or secretion. To test whether GC secretion was associated with GAP 
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formation, we administered the cholinergic agonist carbamylcholine (CCh) to stimulate GC secretion and imaged the small intestine by two-photon microscopy. After CCh administration, the frequency of GAPs increased markedly, as did the amount of luminal antigen colocalized with LP-DCs (Fig. 4e, f) , whereas paracellular leaks or TEDs were unaffected during our imaging time-frame (Fig. 4f ). Furthermore, total LP-DCs, CD103 1 LP-DCs and CD103 2 LP-DCs from CCh-treated mice significantly enhanced the luminal antigen presentation in ex vivo T-cell proliferation assays ( Fig. 4g and Supplementary Fig. 8 ), indicating that GC secretion is linked mechanistically to GAP formation and luminal antigen delivery. We also examined whether the increased number of GAPs in germfree mice ( Fig. 4h and Supplementary Fig. 2e , g) correlated with increased luminal antigen presentation by LP-DCs. LP-DCs from germ-free mice given luminal Ova showed significantly increased antigen presentation capacity compared to LP-DCs from SPF mice. Moreover, luminal antigen delivery in germ-free mice favoured CD103 1 LP-DCs over CD103 2 LP-DCs (Fig. 4i ), similar to observations in SPF mice.
To test directly whether GAPs are a major pathway of antigen delivery to LP-DCs, we generated mice with an epithelial-cell-specific deletion in mouse atonal homologue 1 (Math1), a transcription factor required for the development of secretory cell lineages, including GCs 22 . Math1 fl/flVilCre mice (M1KO) lacked small intestine GCs (Supplementary Fig. 9a -c) and in vivo two-photon imaging revealed a concomitant loss of GAPs, with the epithelium forming a tight barrier to luminal dextran ( Fig. 4j and Supplementary Fig. 9d ). Moreover, LP-DC populations isolated from M1KO mice given luminal Ova failed to stimulate OTI T cells above background levels ( Fig. 4k and Supplementary Fig. 9e ). The lack of antigen presentation by CD103 1 LP-DCs from M1KO mice was not due to an intrinsic defect, because these LP-DCs were capable of inducing robust T-cell proliferation when exogenous Ova was added to the T-cell cultures (Supplementary Fig. 9f ). Taken together, these findings indicate that GAPs are a major mechanism for delivering luminal antigens to LP-DCs in the steady state.
Understanding how the balance between tolerance and immunity is achieved at the intestinal mucosa is crucial for oral vaccine development and the treatment of chronic intestinal inflammatory diseases. This study identifies GAPs as a mechanism by which CD103 1 LP-DCs can acquire innocuous antigens from the intestinal lumen in the steady state. How preferential antigen delivery is achieved is the focus of ongoing studies. Biased delivery could be a natural consequence of CD103 1 LP-DC sampling the epithelium more actively or perhaps being recruited selectively by chemoattractants released by or near GCs. GC deficiency or dysfunction in mice and humans has been linked to the development of intestinal inflammation [23] [24] [25] [26] [27] . Although this association has been attributed to the loss of mucins and other biologically active GC products, our findings suggest that GCs could play a key role in promoting intestinal immune homeostasis by delivering luminal antigen to tolerogenic LP-DCs.
METHODS SUMMARY
Mice and human specimens. All mice were of a C57BL/6 background unless otherwise specified. Healthy human jejunal sections were obtained from bariatric surgeries, placed in PBS containing dextran for 1 h before imaging. Procedures and protocols were carried out in accordance with the institutional review board at Washington University School of Medicine. Fold increase in T cells ) . e, f, Two-photon imaging of GAPs and LP-DCs in CCh-treated mice. CCh increased the number of GAPs and the colocalization of 10 kDa dextran (red) with LP-DCs (green). f, Inset, LP-DCs capturing dextran (yellow arrowheads). g, Luminal antigen presentation by LP-DCs following CCh administration as compared to controls given luminal Ova. h, Germ-free mice had increased GAPs (10 kDa dextran, red; DAPI, blue). i, Luminal antigen presentation by LP-DCs from germ-free mice was significantly enhanced compared to LP-DCs from SPF housed mice. CD103 1 LP-DCs presented luminal antigen significantly better than CD103 2 LP-DCs from germ-free mice. j, Two-photon imaging of intestines in M1KO mice. M1KO mice lacked GAPs (red, 10 kDa dextran) in the epithelium (blue, DAPI). k, Luminal antigen presentation by LP-DCs from M1KO mice was undetectable. Scale bar, 20 mm (a), 40 mm (f). ns, not significant. *P , 0.05, **P , 0.01, ***P , 0.001. Error bars, s.e.m. Data in d, g and k are representative of three or more independent experiments, data in i was representative of two independent experiments. In e, n 5 15 or more images were obtained from three animals for each condition.
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Two-photon microscopy. The intravital imaging preparation used in this study is similar to previously described methods 11, 15 with the following differences: imaging is performed with the tissue within the peritoneal cavity, faecal material is not scraped from the mucosal surface and in some experiments atropine (1 mg kg 21 ) was injected subcutaneously to dampen peristaltic movement of the small intestine. At this dose atropine did not affect the formation of TEDs or the detection of GAPs. Model fluorescent antigens, dextran (2-5 mg), Ova (2 mg), BSA, (2 mg) and FluoSpheres (1 ml undiluted) (all from Invitrogen) were injected into the intestinal lumen approximately 2 h before imaging. Human resection specimens were incubated in 10 mg ml 21 of dextran at room temperature for 1 h before imaging.
